Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs

Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs

Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1,4-...

Full description

Bibliographic Details
Main Authors: Antonio Monge, Mercedes González, Hugo Cerecetto, Beatriz Solano, Ignacio Aldana, Adoración Marín, Raquel Villar, Diego Benítez, Silvia Pérez-Silanes, Asunción Burguete, Saioa Ancizu, Elsa Moreno, Enrique Torres
Format: Article
Language:English
Published: MDPI AG 2009-06-01
Series:Molecules
Subjects:
quinoxaline
neglected diseases
Mycobacterium tuberculosis
Trypanosoma cruzi
Online Access:http://www.mdpi.com/1420-3049/14/6/2256/

Internet

http://www.mdpi.com/1420-3049/14/6/2256/

Similar Items